In vivo studies showed that reduced POSTN expression in pancreatic cancer cells inhibited tumor growth and significantly decreased VEGF expression in mice, which resulted in a decrease in the number of metastases and inhibited angiogenesis. This evidence concerns the gene VEGFA and familial pancreatic carcinoma.